Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Utility of ctDNA in the Treatment of Oligometastatic Disease - A Prospective Observational Clinical Study - A Part of the POB-project

NCT07426250 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT07426250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07426250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Utility of ctDNA in the Treatment of Oligometastatic Disease - A Prospective Observational Clinical Study - A Part of the POB-project
Lead sponsor
Aarhus University Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 17, 2026
Completion date
September 1, 2030
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oligometastatic cancer